Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of oral macimorelin versus insulin tolerance test for diagnosing adult growth hormone deficiency
2015-002337-22Phase 3Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of macimorelin in adult onset growth hormone deficiency (AGHD) (2 arms), sponsored by COSCIENS Biopharma Inc. Primary endpoints: Percent Negative Agreement and Percent Positive Agreement. Started Oct 2015; status: completed.
02
Drugs
macimorelin
03
Conditions
adult onset growth hormone deficiency (AGHD)
Beyond the preview
Go deeper on 2015-002337-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002337-22.